ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,471Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 337

$653K Total Retail Price of All Prescriptions

Rank: 36 out of 337

686 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 686 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 686 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 16,312 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
METOPROLOL TARTRATE 1,075 1,019 1 6
LISINOPRIL 1,067 1,022 2 2
ATORVASTATIN CALCIUM 914 866 3 7
AMLODIPINE BESYLATE 860 848 4 3
SIMVASTATIN 832 760 5 1
OMEPRAZOLE 765 705 6 4
METFORMIN HCL 489 446 7 12
LEVOTHYROXINE SODIUM 472 449 8 5
HYDROCHLOROTHIAZIDE 372 336 9 9
FUROSEMIDE 364 347 10 8
WARFARIN SODIUM 359 359 11 11
METOPROLOL SUCCINATE 349 310 12 21
SERTRALINE HCL 333 314 13 18
ALLOPURINOL 326 291 14 28
LOSARTAN POTASSIUM 320 306 15 15
FLUOXETINE HCL 317 296 16 57
FELODIPINE ER 303 277 17 79
GLYBURIDE MICRONIZED 245 239 R 18 209
LIPITOR 236 220 19 33
PRAVASTATIN SODIUM 207 202 20 14
ZOLPIDEM TARTRATE 194 164 21 23
GLIPIZIDE 183 182 22 45
FLUTICASONE PROPIONATE 171 165 23 34
HYDROCODONE-ACETAMINOPHEN 158 120 S3 24 13
AZITHROMYCIN 142 128 25 51
SYNTHROID 141 135 26 41
POTASSIUM CHLORIDE 138 132 27 62
ADVAIR DISKUS 134 110 28 44
ATENOLOL 134 119 28 10
DIGOXIN 128 117 30 58
ALENDRONATE SODIUM 128 128 30 19
KLOR-CON M20 126 112 32 65
TRAZODONE HCL 125 120 33 16
PREDNISONE 122 109 34 40
GABAPENTIN 113 110 35 20
ZETIA 111 108 36 89
ENALAPRIL MALEATE 109 109 37 37
NIFEDIPINE ER 108 100 38 111
PAROXETINE HCL 107 86 39 46
COMBIVENT 100 81 40 126
KLOR-CON 10 99 95 41 158
RANITIDINE HCL 88 74 42 30
CIPROFLOXACIN HCL 88 86 42 71
MELOXICAM 86 86 44 54
LEVOFLOXACIN 74 66 45 93
TRIAMTERENE-HCTZ 73 66 46 39
TAMSULOSIN HCL 72 72 47 25
CRESTOR 69 68 48 29
PRAZOSIN HCL 69 69 48 293
QUINAPRIL HCL 69 69 48 50
CEPHALEXIN 66 64 51 130
PROAIR HFA 63 40 52 38
ALPRAZOLAM 61 59 53 78
ACTOS 60 60 54 175
DONEPEZIL HCL 60 60 54 22
CEFUROXIME 58 55 56 167
CALCITONIN-SALMON 57 57 57 195
PANTOPRAZOLE SODIUM 56 56 58 36
IBUPROFEN 53 28 59 64
LOVASTATIN 52 52 60 24
PHENYTOIN SODIUM EXTENDED 52 39 60 150
FENOFIBRATE 51 36 62 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.